- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
In this MedPage Opinion piece, the American Medical Association and American Academy of Pediatrics weight in on Murthy v. Missouri, the First Amendment case now before the US Supreme Court.
They present a truly stunning array of factual errors, biased opinions, and unsubstantiated claims.
One is tempted to take them up on the science, or the politics, or the philosophy of "First do no harm," but underlying it all - we should always remember why the First Amendment is indeed First.
https://www.medpagetoday.com/opinion/second-opinions/109343
Medical Misinfo Runs Rampant Online. The Gov't Must Retain the Right to Intervene.
— Combating vaccine falsehoods and other inaccurate claims protects public health
Online misinformation about vaccines harm patients, undermines trust in science, and places additional burdens on our healthcare system through reduced vaccine uptake. All in all, it is a barrier to protecting public health.
As physicians, we see the damages caused by vaccine misinformation firsthand, and we welcome conversations with our patients about vaccine safety and efficacy. However, the widespread proliferation of misinformation and disinformation has triggered higher levels of vaccine hesitancy and refusal, allowing a resurgence of vaccine-preventable diseases such as measles that we had nearly eradicated.
Preventing the spread of vaccine misinformation without infringing on free speech protections in the First Amendment is a thorny legal issue that is at the heart of a landmark case now before the U.S. Supreme Court, Murthy et al. v. Missouri et al. The nation's leading healthcare organizations, including ours (the American Academy of Pediatrics and the American Medical Association) and others -- and the hundreds of thousands of physicians across the country who we represent -- believe that vaccine misinformation poses a grave threat to public health. As outlined in an amicus brief we filed in this case, we seek to partner with the federal government to advance factual information.
In Murthy v. Missouri, plaintiffs including the attorneys general of Missouri and Louisiana argue that several federal agencies and the Biden administration engaged in censorship during the pandemic by urging private social media companies to stop the spread of discredited medical falsehoods from their platforms to save lives. Oral arguments took place last week, and a ruling is expected this summer.
At stake in this case is what tools the government and public health agencies have at their disposal to combat medical misinformation. Without getting into the legal arguments on both sides, one thing is clear: to strip away government power to raise the alarm about patently false information on life-saving vaccines -- when illness and lives hang in the balance -- would be a devastating outcome.
Vaccines have long been one of the safest and most powerful tools in protecting public health. Vaccines save lives by not only protecting vaccinated individuals against infection and reducing the burden of unnecessary hospitalization on our healthcare system, but also by helping prevent the spread of disease.
Medical misinformation that promotes non-scientifically validated remedies can and often does result in harm. Both the FDA and CDC warned of serious adverse effects from people taking ivermectin, an anti-parasitic, to prevent or treat COVID-19, even after numerous studies showed it was entirely ineffective against the virus.
Similarly, one recent study estimated that nearly 17,000 deaths occurred across six nations during the first COVID wave after people took hydroxychloroquine, an antimalaria agent that was wrongly promoted to treat and prevent SARS-CoV-2 infection. Although that was a time of crisis, drug repurposing with low-level evidence can be extremely hazardous and even deadly.
Stopping the spread of medical misinformation is an enormous task, and we cannot expect any single entity to accomplish this challenge. Those of us who have taken an oath to protect the health and well-being of patients share the responsibility to separate fact from fiction.
Anything less than a comprehensive effort to prevent the dissemination of medical misinformation -- using the powers of the federal government, public health agencies, healthcare organizations, social media companies and media outlets, and even individual physicians -- abdicates our responsibility and needlessly puts the health of our communities, and our nation, at risk.
Here's my opinion:
These two organizations in their use of the word "American," prove yet again that they have no idea of its meaning.
Over a month earlier, AAPS took the opposite side of the argument.
For those with long memories, AAPS took down Hilary-Care before it had a chance to become law. In effect, we got another generation of relatively free environment of healthcare - or at least a less oppressive system than it would have given us.
Includes links to its amicus brief.
https://aapsonline.org/aaps-files-amicus-brief-against-biden-administrations-censorship/
AAPS Files Amicus Brief Against Biden Administration’s Censorship
The Association of American Physicians and Surgeons (AAPS) has filed an amicus curiae brief in the U.S. Supreme Court in opposition to the censorship imposed by the Biden Administration by pressuring social media to take down postings critical of Covid vaccination. Set for oral argument on Monday, March 18, this is one of the biggest cases before the Supreme Court this term.
Our national motto is not “In Vaccines We Trust,” or even “In Government We Trust,” AAPS states. “The right to criticize vaccines and government mandates of vaccines should not be abridged as brazenly sought” by the Biden Administration and its allies.
The AAPS amicus brief explains that “vaccine hesitancy” is not a psychological condition, as proponents of censorship pretend, “but rather is justified self-defense against a government that abuses its power by imposing vaccine mandates.”
Citing many historical examples of vaccine failures, this brief points out that the “right to criticize a vaccine is essential especially when government flagrantly ignores safety issues,” as the Biden Administration has concerning Covid vaccines.
“The Surgeon General of Florida, our third largest state, cannot obtain answers from the Biden Administration about safety concerns with Covid vaccines,” states Andrew Schlafly as General Counsel of AAPS. “Instead of censoring issues raised about the Covid vaccines on social media, the Biden Administration officials should be providing answers to the questions raised,” he added.
The AAPS brief is particularly critical of an amicus brief filed by the AMA and other groups supportive of Biden’s vaccination policies. “If adopted, the AMA Amici’s arguments would green-light government censorship of the presidential candidate Robert F. Kennedy, Jr., whose motion to intervene in this case to protect his First Amendment rights was denied by this Court,” AAPS’s brief points out.
“When the federal government tells social media platforms to take action against postings, then our basic free speech rights are gravely endangered,” Mr. Schlafly observes.
This case is captioned Murthy v. Missouri (U.S. Sup. Ct. 23-411). Founded in 1943, the Association of American Physicians and Surgeons is a pro-patient association of physicians in the practice of private medicine. Its motto means “all for the patient.”
Link to amicus brief PDF: https://aapsonline.org/judicial/aaps-amicus-murthy-v-missouri-2-7-2024.pdf
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















